TROMBLEY AETNA WUN enters LYCIA THERAPEUTICS, INC. with 415.25K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 10/22/2026ACC: 0001750495-26-000005
DirectorOfficer10% Owner· President and CEO
Since Oct 2026
415.25K
Baseline shares
0.00
Direct ownership
0 positions
1.64M
Derivative underlying
4 instruments
1
Security positions
415.25K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned415.25K
Total
415.25K indirect415.25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 415.25K | Indirect |
| Total | 415.25K | 415.25K indirect |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
665.38K
Shares owned
N/A
Exercise price
2.44
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
443.59K
Shares owned
N/A
Exercise price
3.70
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
471.25K
Shares owned
N/A
Exercise price
1.63
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
55.45K
Shares owned
N/A
Exercise price
2.35
Expiration
—
Exercise window
—
Total
Underlying
1.64M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 2.44 | — | — | 665.38K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 3.70 | — | — | 443.59K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 1.63 | — | — | 471.25K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 2.35 | — | — | 55.45K | N/A |
| Total | 1.64M | 0.00 | ||||